Military & Military Families

Assessment of Base Rates of PTSD, High Risk Behaviors, and Impairment Study

VOLUNTEERS NEEDED FOR AN ONLINE AND COMPLETELY ANONYMOUS STUDY ON POST-DEPLOYMENT BEHAVIORAL HEALTH OUTCOMES

Are you a Service Member (active duty, National Guard, or Reserve) or Veteran who deployed in support of OIF/OEF?

Are you willing to complete an online, completely anonymous survey?

If so, you may be qualified to participate in an internet study that is examining post-deployment behavioral health outcomes entitled, "Assessment of Base Rates of PTSD, High Risk Behaviors, and Impairment."

Organization: 
Anxiety Disorders Research Program
Principal Investigator: 
John P. Forsyth, PhD
Eligibility Criteria: 

  • Have deployed at least once in support of Operation Enduring Freedom or Operation Iraqi Freedom
  • Be between the ages of 18 and 59
  • Be able to write and read English at an 8th grade level or higher
  • Be willing to respond to a completely anonymous online survey

Contact: 
John P. Forsyth, PhD; actforveterans@gmail.com
Location: 
Online
State: 
New York

ADAA Donates to Military Organizations

11/11/2011

ADAA is donating copies of its calendar Women Talk: Open the Dialogue — Triumph Over Anxiety Disorders to two organizations, Operation HHH, Helping Hands for Heroes and Military Women in Need. These organizations will distribute the calendars at military bases, veterans’ nursing homes, and to other veterans’ organizations.

After the Trauma: How to Manage Anxiety and Stress

9/9/2011

Ten years after the 9/11 terrorist attacks many people continue to struggle with symptoms of anxiety, stress and even posttraumatic stress disorder, or PTSD.

September is Suicide Prevention Awareness Month

8/30/2011

Real Warriors provides brochures, videos, and other free tools to service members, veterans, and their families. They are designed to promote help-seeking behavior and address psychological health concerns.

Treating PTSD and Traumatic Brain Injury

Richard A. Bryant, PhD
Director, Traumatic Stress Clinic
Scientia Professor of Psychology, University of New South Wales
Sydney, Australia

Dr. Bryant talks about  the intersection of traumatic brain injury (TBI) and PTSD, including treatment and how therapy needs to be adapted for TBI survivors.

Listen

Anxiety Disorders (Pediatric) Research Study

This study examines whether an antibiotic, d-cycloserine (DCS), boosts the effectiveness of cognitive behavior therapy (CBT) for social anxiety. CBT has been shown to be effective for the treatment of social anxiety in children and adults, but even after treatment, approximately 40% may remain diagnosable. All participants will receive 12 weekly CBT sessions. In addition to receiving the CBT, participants will be randomly assigned (similar to a coin toss) to receive either DCS or a placebo (sugar pill). The pill will be taken 1-2 hours prior to each of the 12 CBT sessions.

Organization: 
NIMH
Principal Investigator: 
Jennifer A. Cameron, Ph.D.
Eligibility Criteria: 
  1. Subjects between 8 yrs of age (preadolescents) and under 55 yrs of age.
  2. Subjects medically healthy.
  3. Able to give informed consent.
  4. Not on psychotropic meds for a minimum of 6 weeks for fluoxetine; a minimum of 1 week for PRN benzodiazepines and beta blockers, and a minimum of 3 weeks for all other psychotropic meds.
  5. Subjects diagnosed with DSM IV symptoms of social phobia, generalized or specific type.
Exclusion Criteria: 
  1. Current major depressive disorder.
  2. Lifetime diagnosis of psychotic disorder, bipolar disorder, eating disorder, mental retardation, substance or alcohol dependence (other than nicotine); active suicidal ideation.
  3. Current or lifetime history of a neurological disorder (other than tic disorders, febrile seizures of infancy), seizure disorder.
  4. Any unstable medical condition.
  5. Use of any psychoactive substance in the past 30 days.
Contact: 
(800) 411-1222, prpl@mail.cc.nih.gov
Location: 
Bethesda, MD
State: 
Maryland

Anxiety Disorders (Pediatric) Research Study

This study uses functional magnetic resonance imaging (fMRI) to learn how the brain functions in adolescents receiving fluoxetine (Prozac) or cognitive behavioral therapy (CBT) for anxiety or depression in children/adolescents. All participants will receive interviews to assess how they are doing in general, including his or her general mood, degree of nervousness and behavior. Each participant and one of his or her parents will be interviewed separately and together.

Organization: 
NIMH
Principal Investigator: 
Daniel S. Pine, MD; 301-594-9960, Daniel.Pine@nih.hhs.gov
Eligibility Criteria: 

JUVENILE SUBJECTS

Age: 8 to 17

Consent: Can give consent/assent. (Parents will provide consent; minors will provide assent.)

IQ: All subjects will have IQ greater than 70 (Assessment relies on WASI)

SUBJECTS WITH AN ANXIETY DISORDER

Diagnosis: Current Diagnosis of Social Phobia, Separation Anxiety, or Generalized Anxiety Disorder (Based on K-SADS)

Symptom Severity: Score greater than 9 on PARS (This score was used to enroll subjects in previous trial demonstrating efficacy of an SSRI in pediatric anxiety.)

Clinical Impairment: CGAS less than 60

SUBJECTS WITH A MOOD DISORDER

Diagnosis: Current Diagnosis of Major Depression (Based on K-SADS (juveniles) or SCID (adults))

Clinical Impairment: CGAS less than 60 (juveniles) GAS less than 70 (adults)

Symptom Severity: CDRS Score greater than 39 (juveniles) (This score was used to enroll subjects in previous trials demonstrating efficacy of an SSRI in pediatric depression.)

ADULT SUBJECTS

Age: 20-40

Consent: Can give consent/assent.

IQ: All subjects will have IQ greater than 70. Assessment relies on WASI.

Exclusion Criteria: 

ALL SUBJECTS:

Any serious medical condition or condition that interferes with fMRI scanning, and for patients electing medication, any condition that increases risk of SSRI treatment. All patients will have complete physical examination. Healthy volunteer participants will be medication-free and have no current serious medical conditions, based on a review of their medical history.

Pregnancy

Current use of any psychoactive substance; current suicidal ideation; current diagnosis of attention deficit hyperactivity disorder (ADHD) of sufficient severity to require pharmacotherapy. These factors could complicate treatment with an SSRI. No subject on medication will be accepted into the trial. Subjects will not be taken off of medications to enter the trial.

Current diagnoses: Tourette's, OCD, posttraumatic distress disorder, conduct disorder. These factors may be effected by SSRI treatment, influencing ability to detect effects on anxiety/depression

Past or current history of mania, psychosis, or pervasive developmental disorder. These factors may be effected by SSRI treatment, influencing ability to detect effects on anxiety/depression

Recent use of an SSRI: All subjects must have been free of any SSRI use for at least one month (fluoxetine six months) and must not have been treated with an SSRI for their current depressive episode. This is designed to exclude subjects who have failed a trial of an SSRI for their current episode of major depression.

HEALTHY ADULT SUBJECTS

Any current psychiatric diagnosis. Assessment relies on SCID.

SUBJECTS WITH AN ANXIETY DISORDER

Current Major Depressive Disorder

Contact: 
Allison M. Detloff, 301-451-6817, detloffa@mail.nih.gov
Location: 
Bethesda
State: 
Maryland
Study End Date: 
Tue, 2013-12-31

News and Research

Female Vets: Greater Likelihood of Suicide

The suicide rate among young (18 to 34 age group) female U.S. military veterans is nearly three times higher than among civilian women, a new study has found. Clinicians should inquire about military service among women and should recognize that suicide-prevention practices pertain to female veterans. (Psychiatric Services, 61:1177, December 2010) Read more. 

Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for PTSD

The purpose of this study is to evaluate the equivalence of CPT treatment delivered remotely via telemental health (TMH) over videoconferencing or via traditional face-to face (FTF) treatment to veterans who have posttraumatic stress disorder (PTSD) from a military-related stressor (i.e., combat, sexual assault, non-combat physical assault).

 

Organization: 
University of Wisconsin, Madison, and Department of Veterans Affairs
Principal Investigator: 
Tracey L Smith, PhD
Eligibility Criteria: 
  • 18 years of age or older
  • Literate in written English
  • Fluent in spoken English
  • Verified status as an OEF/OIF veteran
  • Current PTSD diagnosis
  • Index traumatic event related to military services
  • If taking psychotropic medication, remains stable
Exclusion Criteria: 
  • Under 18 years of age
  • Not literate in written English
  • Not fluent in spoken English
  • Current uncontrolled psychotic or bipolar disorder
  • Substance dependence
  • Current uncontrolled suicidal or homicidal ideation
  • Significant cognitive impairment that would interfere with completion of therapy tasks
Contact: 
Yanmin A Li, MBBS, 608-263-4290 or ali@clinicaltrials.wisc.edu, or Lori Wollet, RN, 608-262-6855 or lw3@clinicaltrials.wisc.edu
Location: 
Madison, WI
State: 
Wisconsin

Contact ADAA

8701 Georgia Ave. #412
Silver Spring, MD 20910

240.485.1001

Contact ADAA

Request Publications

FacebookTwitterRSS

Syndicate content RSS

 

ADAA is a national nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, OCD, PTSD, depression, and related disorders and to improving the lives of all people who suffer from them.